Satellite Symposium (V) - Takeda
The First Gut-Selective Treatment for IBD: From Pivotal Trial to Long-Term Real-World Experience
Conference Room D, NTUH International Convention Center
| Time | Topic | Speaker | Moderator |
|---|---|---|---|
| Real-World Evidence on Safety and Long-Term Efficacy of Vedolizumab | Ian Lawrance
Australia |
Chia-Long Lee
Cathay General Hospital
|
|
| Optimizing Use of Biologic in IBD: Long Term Efficacy and Safety Perspective | Daniel Hommes
University of California, Los Angeles
|
Ming-Chih Hou
Taipei Veterans General Hospital
|